Hints and tips:
...Rumour has it that it was Dennis Hopper who reminded him of the work’s existence....
...Dennis K Berman is a managing director in Lazard’s shareholder advisory practice...
...According to SEC filings, Elon Musk’s company is the $60bn hedge fund’s second largest holding, behind Bristol-Myers Squibb....
...Another earnings-driven move on Thursday came from pharmaceutical group Bristol-Myers Squibb, which fell 4.8 per cent to $60.95 after it narrowly missed Wall Street forecasts for third-quarter earnings....
...Other investors lower down the Tesco share register were far more positive about Mr Allan, who began his career at Lever Brothers and Bristol-Myers in a variety of marketing roles....
...Mr Kim’s most successful publicity stunt to date has been his warm treatment of Dennis Rodman and other African-American basketball players....
...Myer Holdings jumped 4.9 per cent to A$1.62, and Harvey Norman Holdings advanced 2.6 per cent to A$1.95. The S&P/ASX 200 climbed 1.2 per cent to 4,094.63....
...Myer , the department store group, rose 10 per cent on the week to A$2.63 and rival David Jones gained 11.4 per cent to A$3.52. Sydney’s S&P/ASX 200 climbed 5.1 per cent to 4,353.27....
...drugmaker Bayer fell 6.3 per cent to €54.40 after Xarelto, its blockbuster blood thinner, was found to perform less well in clinical trials than Apixaban, a new rival being developed by US peers Bristol-Myers...
...Its existence in Uganda was first traced in the 1920s when EJ Wayland, a British geologist, mapped a series of seepages along the banks of Lake Albert....
...Instead, stories of failed deals dominated after reports suggested Sanofi-Aventis, the French drugmaker, had ended talks with Bristol-Myers Squibb. Sanofi shares gained 0.4 per cent to €67.80....
...The French drugmaker refused to comment on weekend speculation that talks about a possible takeover of US peer Bristol-Myers Squibb have ended....
...Sanofi-Aventis was the worst performing stock on the CAC 40 index in Paris after a French newsletter sparked rumours of a merger with Bristol-Myers Squibb of the US....
...Rumours persisted that French drugmaker Sanofi-Aventis was poised to announce a merger with US partner Bristol-Myers Squibb....
...Meanwhile, France’s Sanofi-Aventis fell 0.6 per cent to €69.70 after Bristol-Myers Squibb said its third-quarter earnings dropped as sales of Plavix, the blood thinner it sells in partnership with Sanofi...
...Along with US partner Bristol-Myers Squibb, Sanofi requested a preliminary injunction to halt sales by Apotex of a generic form of the blood-thinning drug....
...Myers Industries, the plastics manufacturer, said currency effects hit fourth-quarter net profit, but shares leapt 7.1 per cent to $15.42 after it said it might sell non-core assets....
...Bristol-Myers Squibb reportedly began clinical testing a gamma-secretase inhibitor in 2001 and stopped because of side-effects, but it has never publicly reported those results....
...Other corporate news this week included settlements with regulators by Halliburton and Bristol Myers-Squibb....
International Edition